TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Indoco Remedies Limited ( (IN:INDOCO) ) has shared an update.
Indoco Remedies Limited has announced a substantial acquisition of shares by its promoters, Aditi Milind Panandikar and Aruna Suresh Kare, through the Kare Family Private Trust (KFPT). This acquisition involves both direct and indirect purchases, including significant stakes in the promoter company Shanteri Investment Private Limited (SIPL), which will enhance KFPT’s influence in Indoco Remedies. This move is likely to strengthen the promoters’ control over the company and could have implications for its strategic direction and shareholder dynamics.
More about Indoco Remedies Limited
Indoco Remedies Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical formulations. The company is known for its wide range of therapeutic products and has a significant presence in both domestic and international markets.
Average Trading Volume: 20,327
Technical Sentiment Signal: Sell
Current Market Cap: 24.16B INR
See more data about INDOCO stock on TipRanks’ Stock Analysis page.